Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Tarcocimab tedromer - Phase 3 | KOD Pipeline | CatalystAlert

Tarcocimab tedromer

Phase 3

Kodiak Sciences Inc (KOD)

63%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Aug 2026~

KOD⭐Phase 3Phase 3

Tarcocimab tedromer Phase 3 Results Expected

Tarcocimab tedromer • Wet Age-related Macular Degeneration

Drug Information

Target Indication

Wet Age-related Macular Degeneration

Clinical Trial

Last updated: 12/4/2025

Developer

KOD

Kodiak Sciences Inc

Biotechnology•North America•NASDAQ